By API User
Key points Australian researchers have found ‘switching off’ an enzyme called CaMKK2 in mice prevents diet-induced obesity, diabetes and fatty liver disease When CaMKK2 was deleted, the mice were shown to display healthier gene activity in their immune cells and fat tissue, and burned more energy overall The study establishes CaMKK2 as a therapeutic target for … Continued
By API User
Key Facts: Thirteen new specialist GP received their papers, including two Rural Generalists, and four NT GPs also received Rural Generalist papers Fellowship of the RACGP (FRACGP) reflects qualification as a specialist GP after around 11 years of education, training and assessment Rural Generalists undertake an additional year of training in emergency medicine and other … Continued
By API User
A new eyedrop has shown early success in delivering protective compounds to where they’re needed most in the eye, raising hopes for less invasive treatment of serious vision conditions. The research led by RMIT University is focused on retinal diseases, especially age-related macular degeneration (AMD). AMD damages the retina, specifically the macula, which can cause … Continued
By API User
Angelini Pharma secures exclusive option to license global development and commercialization rights for SVG1051, a pre-clinical investigational novel compound with broad potential to treat brain health diseases, excluding the Republic of Korea, China, Hong Kong, Macau and Taiwan Sovargen receives upfront payment and is eligible for future milestone-dependent payments and royalties Agreement further expands Angelini … Continued
By API User
From next year, South Australian children aged 2–5 years will be able to receive needle-free influenza vaccinations via their GP, a move the Royal Australian College of GPs (RACGP) has described as “lifesaving”. Needles act as a major barrier to childhood vaccinations, and from 2026, GPs will deliver these vaccines via a spray into a … Continued
By API User
TAIZHOU, Jiangsu, Sept. 21, 2025 (GLOBE NEWSWIRE) — Most recently, the Phase III pivotal clinical trial results of Fazamorexant, a first-class innovative anti-insomnia drug independently developed by Yangtze River Pharmaceutical Group,were globally unveiled for the first time at the World Sleep Congress 2025 combined with the annual meeting of the Asian Society of Sleep Medicine … Continued
By API User
Palliative Care Australia (PCA) has welcomed the formal recognition of Rural Generalist Medicine as a medical specialty in Australia. PCA CEO Camilla Rowland said that this was a historic moment that honours the extraordinary role of rural generalists who provide comprehensive care – from GP services to emergency, hospital, and palliative care – in … Continued
By API User
Breakthrough Australian device to treat Alzheimer’s receives Federal Government funding Brisbane-based company Ceretas has been awarded a $2.4 million grant to fast-track development of its next-generation therapeutic ultrasound device – an Australian-designed innovation aiming to transform the treatment of Alzheimer’s disease. The competitive grant was awarded through the CUREator+ Dementia & Cognitive Decline program, part of … Continued
By API User
Australia’s leading general practice training college, the Royal Australian College of GPs (RACGP), has proudly welcomed 84 new specialist GPs at a Fellowship ceremony on Friday in Perth. Fellowship of the RACGP recognises a doctor’s qualification and expertise as a specialist GP. Achieving Fellowship represents the gold standard of general practice in Australia, typically following … Continued
By API User
Melbourne, Australia – Monday 22 September 2025 – The CUREator + Dementia and Cognitive Decline BioMedTech Incubator today announced seven companies will receive $15,765,871 in non-dilutive funding. With funding from the Australian Federal government’s Department of Health, Disability and Aged Care and the Medical Research Future Fund, CUREator+ supports the development and commercialisation of medical … Continued
